As on Wednesday, Cullinan Therapeutics Inc (NASDAQ: CGEM) got off with the flyer as it spiked 7.68% to $10.94, before settling in for the price of $10.16 at the close. Taking a more long-term approach, CGEM posted a 52-week range of $5.68-$13.33.
The Healthcare Sector giants’ yearly sales growth during the last 5-year period was -45.66%. Meanwhile, its Annual Earning per share during the time was -45.66%. Nevertheless, stock’s Earnings Per Share (EPS) this year is -27.50%. This publicly-traded company’s shares outstanding now amounts to $59.08 million, simultaneously with a float of $38.96 million. The organization now has a market capitalization sitting at $646.29 million. At the time of writing, stock’s 50-day Moving Average stood at $9.74, while the 200-day Moving Average is $8.17.
Cullinan Therapeutics Inc (CGEM) Ownership Facts and Figures
Another important factor to analyze is how key investors are playing towards the stock of the Biotechnology industry. Cullinan Therapeutics Inc’s current insider ownership accounts for 34.05%, in contrast to 77.35% institutional ownership. According to the most recent insider trade that took place on Dec 23 ’25, this organization’s President and CEO sold 9,922 shares at the rate of 10.01, making the entire transaction reach 99,319 in total value, affecting insider ownership by 420,699. Preceding that transaction, on Dec 19 ’25, Company’s Chief Scientific Officer sold 1,345 for 10.01, making the whole transaction’s value amount to 13,463. This particular insider is now the holder of 132,635 in total.
Cullinan Therapeutics Inc (CGEM) Earnings and Revenue Records
Cullinan Therapeutics Inc’s EPS decrease for this current 12-month fiscal period is -27.50% and is forecasted to reach -3.03 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 1.65% through the next 5 years, which can be compared against the -45.66% growth it accomplished over the previous five years trading on the market.
Cullinan Therapeutics Inc (NASDAQ: CGEM) Trading Performance Indicators
Let’s observe the current performance indicators for Cullinan Therapeutics Inc (CGEM). It’s Quick Ratio in the last reported quarter now stands at 10.45.
In the same vein, CGEM’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -3.68, a figure that is expected to reach -0.78 in the next quarter, and analysts are predicting that it will be -3.03 at the market close of one year from today.
Technical Analysis of Cullinan Therapeutics Inc (CGEM)
Through scrutinizing the latest numbers posted by the [Cullinan Therapeutics Inc, CGEM], it can be observed that its last 5-days Average volume of 0.81 million was lower the volume of 0.84 million, it posted the year before. During the previous 9 days, stock’s Stochastic %D was recorded 60.66% While, its Average True Range was 59.63.
Raw Stochastic average of Cullinan Therapeutics Inc (CGEM) in the period of the previous 100 days is set at 68.76%, which indicates a major fall in contrast to 78.87% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 0.60 that was lower than 0.64 volatility it exhibited in the past 100-days period.
